Future directions in mucormycosis research

Dimitrios P. Kontoyiannis; Russell E. Lewis; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roillides; Ashraf Ibrahim; Thomas J. Walsh

doi:10.1093/cid/cir886

Future directions in mucormycosis research

Dimitrios P. Kontoyiannis, Russell E. Lewis, Oliver Lotholary, Brad Spellberg, Georgios Petrikkos, Emmanuel Roillides, Ashraf Ibrahim, Thomas J. Walsh

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.

Original language	English (US)
Pages (from-to)	S79-S85
Journal	Clinical Infectious Diseases
Volume	54
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1093/cid/cir886
State	Published - Feb 1 2012

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/cir886

Cite this

@article{df442f28efe948cdb25a00068bd3b4f7,

title = "Future directions in mucormycosis research",

abstract = "Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.",

author = "Kontoyiannis, {Dimitrios P.} and Lewis, {Russell E.} and Oliver Lotholary and Brad Spellberg and Georgios Petrikkos and Emmanuel Roillides and Ashraf Ibrahim and Walsh, {Thomas J.}",

note = "Funding Information: Financial support. This research is supported in part by the National Institutes of Health through MD Anderson{\textquoteright}s Cancer Center Support Grant CA016672.",

year = "2012",

month = feb,

day = "1",

doi = "10.1093/cid/cir886",

language = "English (US)",

volume = "54",

pages = "S79--S85",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Future directions in mucormycosis research

AU - Kontoyiannis, Dimitrios P.

AU - Lewis, Russell E.

AU - Lotholary, Oliver

AU - Spellberg, Brad

AU - Petrikkos, Georgios

AU - Roillides, Emmanuel

AU - Ibrahim, Ashraf

AU - Walsh, Thomas J.

N1 - Funding Information: Financial support. This research is supported in part by the National Institutes of Health through MD Anderson’s Cancer Center Support Grant CA016672.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.

AB - Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=84855869013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855869013&partnerID=8YFLogxK

U2 - 10.1093/cid/cir886

DO - 10.1093/cid/cir886

M3 - Article

C2 - 22247450

AN - SCOPUS:84855869013

SN - 1058-4838

VL - 54

SP - S79-S85

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - SUPPL. 1

ER -

Future directions in mucormycosis research

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this